freedoublejokerpoker| The concept of stem cells rose in early trading, and many stocks such as Guanhao Biotech rose

thematicfreedoublejokerpoker: A-shares 'upward volume breakthrough focuses on the post-holiday fund replenishment effect

On May 8, it was reported that the concept of stem cells was widely promoted in early trading, and many constituent stocks such as Guanhao Biotech, Kaineng Health, Tailin Biotech, Zhongyuan Xiehe, Jimin Medical, Nanhua Biotech, Berry Gene, and Nanjing Xinbai had a daily limit.

In the news, Yin Hao's team from Shanghai Changzheng Hospital and Cheng Xin's team from the Chinese Academy of Sciences successfully cured a type 2 diabetic patient with severely impaired islet function using stem cell-derived autologous regenerative islet transplantation therapy for the first time in the world. The patient has been completely removed from insulin for 33 months. Relevant results were published in the international journal Cell Discovery.